Use of urinalysis tests limited for supervised individuals.
Summary
HF3968 would change Minnesota corrections law governing people on parole, supervised release, or conditional release by limiting when the Department of Corrections may require urinalysis testing. Under the bill, a supervised individual could be ordered to submit to a urinalysis test only when there is reasonable suspicion of illicit drug use, and the basis for that suspicion must be documented in the supervision authority’s case management system. The bill is aimed at narrowing routine or suspicionless drug testing for people under supervision.
The bill also updates release-condition rules related to cannabis and hemp products. It would allow the commissioner of corrections to prohibit use of adult-use cannabis flower, adult-use cannabis products, hemp-derived consumer products, and lower-potency hemp edibles only when a chemical use assessment shows abstinence is consistent with the recommended level of care. At the same time, the commissioner could not bar a person on release from participating in the state cannabis registry program, and could not revoke or sanction someone solely for registry participation or for a positive test for cannabis components or metabolites. The bill amends Minnesota Statutes 2024, section 244.05, subdivision 2.
In practical terms, the bill would affect the Department of Corrections, supervision agents, and people on parole or supervised release by tightening the circumstances under which drug testing and related sanctions may occur. It would also interact with Minnesota’s newer cannabis and hemp laws by limiting how those products can be treated as release-condition violations. The measure appears to be a policy shift toward more targeted supervision and away from automatic punishment based on cannabis use or cannabis-related test results.
The available context shows no recorded committee testimony or votes, so there is no documented public debate in the materials provided. Based on the bill text, the likely overall sentiment is reform-oriented and protective of supervised individuals’ rights, while still preserving supervision tools when there is documented reasonable suspicion. The main point of contention is likely to be whether limiting urinalysis to reasonable suspicion reduces the Department of Corrections’ ability to monitor compliance and public safety, versus whether it prevents unnecessary testing and sanctions for cannabis-related conduct that is increasingly lawful under state law.
Impact
The bill would amend Minnesota Statutes section 244.05, subdivision 2, by restricting the Department of Corrections’ authority to require urinalysis testing of supervised individuals and by limiting release conditions tied to cannabis and hemp products. It would require documented reasonable suspicion before a supervision agent can order a urinalysis test, and it would prohibit sanctions based solely on participation in the cannabis registry program or a positive cannabis test. The bill would also constrain when abstinence from cannabis or hemp products can be imposed as a release condition, tying that decision to a chemical use assessment and recommended level of care.
Sentiment
No committee transcripts or vote history were provided, so there is no direct record of support or opposition in the materials. The bill’s text suggests a reform-minded approach that is likely to be viewed favorably by advocates for reduced supervision burdens and cannabis policy consistency, while potentially drawing concern from corrections officials or public safety advocates who prefer broader drug-testing authority. Overall, the bill appears to reflect a cautious but permissive stance toward cannabis use by supervised individuals, especially where no individualized suspicion exists.
Contention
The main likely point of contention is the bill’s restriction of urinalysis testing to cases with documented reasonable suspicion. Supporters would likely argue this protects due process, reduces unnecessary surveillance, and avoids penalizing people for lawful or low-risk cannabis use. Opponents may argue that it limits a supervision agent’s discretion and could make it harder to detect relapse or noncompliance. A second area of tension is the bill’s treatment of cannabis and hemp products: it prevents sanctions based solely on registry participation or cannabis-positive tests, which may be seen as aligning supervision rules with Minnesota’s cannabis legalization framework, but could be criticized as weakening enforcement tools for people under correctional supervision.
Level III predatory offenders required to be subject to electronic surveillance while under community correctional supervision, and money appropriated.
American Indian incarcerated individuals cultural program modified, community supervision reporting requirements clarified, federal law enforcement agents who transport persons exempted from definition of protective agent, and obsolete civil commitment law regarding incarcerated individuals with mental illness repealed.